ComInnex

Budapest, Hungary Founded: 2006 • Age: 20 yrs Acquired By X-Chem
Custom chemical synthesis and business development services are provided.

About ComInnex

ComInnex is a Chemicals & Materials company based in Budapest (Hungary) founded in 2006, and was acquired by X-Chem in October 2021. Custom chemical synthesis and business development services are provided. Its chief executive, as recorded, is Alexander Drijver. ComInnex offers products and services including DNA-Encoded Libraries (DEL) and ArtemisAI Platform. Its focus areas include Chemicals and Materials and Chemical Services. Its legal entity is X-Chem, Inc.

Company details

ComInnex was founded in 2006 and is based in Budapest, Hungary. Operations focus on the chemical sector, where custom synthesis services are offered alongside business development support. Additional services are provided to clients in related fields. The company is led by CEO Alexander Drijver, with activities centered in Europe. Expertise in chemical processes is utilized to meet specific project needs.

  • Headquarters Budapest, Hungary
  • Stage Acquired
  • Sectors
    Chemicals & Materials
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website cominnex.com
  • Social LinkedIn X Facebook
  • Acquired by X-Chem (Oct 2021)
  • Legal Name X-Chem, Inc.
Key Metrics
  • Latest Funding Round
    $281.72K (USD), Grant

    Jan 2021

  • Investors
    X-Chem

    & 1 more

  • Acquired by
    X-Chem

    (Oct 2021)

Products & Services of ComInnex

ComInnex offers a comprehensive portfolio of products and services, including DNA-Encoded Libraries (DEL) and ArtemisAI Platform.

DNA-Encoded Libraries (DEL)
Drug Discovery Services

DEL technology is utilized for screening and identifying small molecule candidates in various therapeutic areas.

ArtemisAI Platform
AI Solutions

The ArtemisAI platform is employed to analyze data and generate insights for accelerating drug discovery processes.

Funding Insights of ComInnex

  • Total Rounds 2
  • Last Round Grant β€” $281,716
  • First Round $476,808

    (Jan 2020)

  • Investors Count 1

All 2 funding rounds of ComInnex with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2021$281,716Grant––
Jan 2020$476,808Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in ComInnex

ComInnex has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include X-Chem and European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Small molecule drug discovery platform is provided to researchers.
2009x-chemrx.comWaltham, United States
Premium access

Investor details for ComInnex

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of ComInnex

1 people are tracked at ComInnex (1 in leadership).

NameRoleGroup
Alexander Drijver
CEOLeadership
Premium access

Complete people profiles for ComInnex

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of ComInnex

4 dated milestones of ComInnex across 15 years, from founding to its latest funding, stage changes and deals.

  1. Founded ComInnex is founded.
  2. Funding First funding round of $477K.
  3. Funding Latest funding round, Grant, of $282K.
  4. Exit Acquired by X-Chem.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about ComInnex

ComInnex was founded in 2006 and raised its 1st funding round 14 years after it was founded.

ComInnex is headquartered in Budapest, Hungary.

Alexander Drijver is the CEO of ComInnex, as recorded in our data.

ComInnex was founded in 2006 and is based in Budapest, Hungary. Operations focus on the chemical sector, where custom synthesis services are offered alongside business development support. Additional services are provided to clients in related fields. The company is led by CEO Alexander Drijver, with activities centered in Europe. Expertise in chemical processes is utilized to meet specific project needs.

ComInnex offers DNA-Encoded Libraries (DEL) and ArtemisAI Platform.

ComInnex has 2 investors. Key investors include X-Chem, and European Union.

ComInnex operates through X-Chem, Inc..

Yes. ComInnex was acquired by X-Chem in October 2021.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available